Navigation Links
OpenQ Announces openSpend for Physician Payment Sunshine Act Compliance
Date:1/8/2010

OpenQ puts easy-to-use aggregate spend management solution into general release

Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France (PRWEB) January 8, 2010 -- OpenQ announces the general release of openSpend, an integrated information, service and software solution for managing and reporting aggregate spend. The company will be officially launching the product while sponsoring ExL Pharma’s Tracking & Reporting Aggregate Spend Conference taking place January 12-13, 2010 at the Grand Hyatt Hotel in Washington DC.

OpenQ is the industry leader in compliance solutions and key relationship management and research for pharmaceutical, biotech, and medical device companies.

Designed to meet the requirements included in America’s Affordable Health Choices Act, along with recent federal and state legislation, openSpend satisfies a vital and imminent need for life science companies. OpenSpend includes the following key capabilities:

 
  • Management dashboard
  • Easy-to-implement connectors to spend transaction systems
  • Wizard-driven spend entry portal
  • Contract tracking module
  • Internal and external reporting with filtering and ad hoc
  • Configurable workflow and approval management
  • openQ proprietary research feeds and algorithms for validation, identity matching and legislative updates

“Pharmaceutical, medical device and biotech companies can now count on openQ to help them meet another critical compliance need: aggregate spend management,” said Jim Zuffole
'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm
2. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
3. OpenQ is Awarded Prestigious Life Sciences Industry Award
4. D-Pharm (TASE: DPRM) Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI
5. China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option
6. Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer
7. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
8. Poniard Pharmaceuticals Announces $6.5 Million Financing
9. AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
10. American Oriental Bioengineering Announces the Inclusion of 158 Drugs in Chinas National Insurance Catalog
11. Martek Announces Fourth Quarter and FY 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenQ Announces openSpend for Physician Payment Sunshine Act Compliance
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, a Clinical ... relationships with local sponsors in southern California. The Clinical Trial Management Expert CRO seeks ... and regulatory pathways., , Stem Cell Meeting on the ...
(Date:8/25/2015)... 25, 2015   WuXi PharmaTech (Cayman) Inc. (NYSE: ... technology platform company serving the pharmaceutical, biotechnology, and medical ... Hong Kong Exchange Stock Code: 0950), a research-based biopharmaceutical ... with 20 years of operations in China ... signed an agreement whereby WuXi,s Laboratory Testing Division (LTD) ...
(Date:8/25/2015)... Menomonie, Wis. (PRWEB) , ... August 25, 2015 ... ... and fermentor at its research facility in Knapp, Wis. The company has added ... Biostat C15 Fermentor allows detailed data collection during bacterial or fungal fermentation process ...
(Date:8/25/2015)... ... 2015 , ... One of the world’s foremost authorities on supply chain risk ... been on a mission for the past two weeks. She’s been scrambling to warn ... the two massive explosions that occurred on August 12 at the Ruihai International Logistics ...
Breaking Biology Technology:PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3New centrifuge and fermentor expand product development capacity at Vets Plus 2Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 2Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 3Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 4
... the Board of Directors,meeting held today, the Directors ... The dividend is payable on December 15, 2008 ... About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science ... products and kits,are used in scientific and genomic ...
... 11 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: BJGP ... due to the technical difficulties encountered on,today,s conference ... tomorrow,Wednesday, November 12, 2008. On this call, BMP ... since technical difficulties prevented the,Company from addressing all ...
... molecule detection to expand prominent Scientific Advisory ... ... 11 Quanterix Corporation, the,leader in single molecule detection, announced today ... Corn is a,Professor in the Departments of Chemistry and Biomedical Engineering ...
Cached Biology Technology:BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesday's Call 2BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesday's Call 3Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board 2
(Date:8/6/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced collaboration with Microsoft on biometric fingerprint ... leveraged Synaptics, deep expertise in human interface which ... Through stringent testing, Synaptics, advanced image sensing ... Precision TouchPad (PTP) specification empowering OEMs with Windows ...
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... Boston University School of Medicine (BUSM) have identified a ... response and homeostasis. These findings could help lead to ... associated with cancer, type 2 diabetes and other diseases. ... PhD, assistant professor of biochemistry at BUSM, was done ...
... This press release is available in German . ... is a key feature of human evolution. In particular, humans ... individuals. Chimpanzees and orangutans, two of our closest living relatives, ... generation to another. Whether and how this process resembles the ...
... a warning for obese women who are planning pregnancies. Even if ... will develop in an unhealthy environment that places the infants at ... in the placentas of obese mothers when it should be going ... in the placenta of an obese mother is half the size ...
Cached Biology News:BUSM researchers identify key regulator of inflammatory response 2Majority-biased learning 2U of I study: Lose body weight before gaining baby weight 2
Request Info...
... StabilZyme HRP Conjugate Stabilizer is an ... protein and other non-toxic stabilizing chemicals in ... 6.2 6.7. This product contains ... and 20 ppm Proclin 300 (Rohm and ...
Preparation Note: by a modification of the procedure of C.W. Hancher et al., Biotechnol. Bioeng. 11, 1055 (1969) Assay: ~ 20 A 260 /mg Solubility: water 10 mg/mL, clear, light-yellow Suitab tst...
Request Info...
Biology Products: